Works matching IS 03125963 AND DT 2021 AND VI 60 AND IP 3
Results: 10
Clinical Pharmacokinetics of Daptomycin.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 271, doi. 10.1007/s40262-020-00968-x
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 283, doi. 10.1007/s40262-020-00967-y
- By:
- Publication type:
- Article
Population Pharmacokinetics of Levetiracetam: A Systematic Review.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 305, doi. 10.1007/s40262-020-00963-2
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 379, doi. 10.1007/s40262-020-00946-3
- By:
- Publication type:
- Article
Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 353, doi. 10.1007/s40262-020-00945-4
- By:
- Publication type:
- Article
Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 329, doi. 10.1007/s40262-020-00944-5
- By:
- Publication type:
- Article
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 319, doi. 10.1007/s40262-020-00943-6
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 365, doi. 10.1007/s40262-020-00940-9
- By:
- Publication type:
- Article
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 391, doi. 10.1007/s40262-020-00938-3
- By:
- Publication type:
- Article
Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 337, doi. 10.1007/s40262-020-00935-6
- By:
- Publication type:
- Article